Patents Assigned to BioRegency, Inc.
  • Compositions and methods relating to argininosuccinate synthetase
    Patent number: 10646555
    Abstract: Processes and compositions for the therapeutic treatment of pathogenic Gram-negative bacterial infection are provided whereby argininosuccinate synthetase or PEGylated argininosuccinate synthetase is administered to a subject to inactivate endotoxin thereby reducing the likelihood of bacterial sepsis and improving patient outcome.
    Type: Grant
    Filed: June 16, 2017
    Date of Patent: May 12, 2020
    Assignee: BioRegency, Inc.
    Inventors: Stanislav I. Svetlov, Victor Prima, Alvin Wang, Gabriel Molina, Kevin Ka-wang Wang